Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
7.55
-0.23 (-2.96%)
At close: Dec 5, 2025, 4:00 PM EST
7.55
0.00 (0.00%)
After-hours: Dec 5, 2025, 5:01 PM EST
Fennec Pharmaceuticals Revenue
Fennec Pharmaceuticals had revenue of $12.46M in the quarter ending September 30, 2025, with 78.69% growth. This brings the company's revenue in the last twelve months to $38.79M, down -21.39% year-over-year. In the year 2024, Fennec Pharmaceuticals had annual revenue of $47.54M with 123.69% growth.
Revenue (ttm)
$38.79M
Revenue Growth
-21.39%
P/S Ratio
5.36
Revenue / Employee
$1,212,188
Employees
32
Market Cap
257.86M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 47.54M | 26.29M | 123.69% |
| Dec 31, 2023 | 21.25M | 19.72M | 1,284.50% |
| Dec 31, 2022 | 1.54M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 170.00K | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
FENC News
- 3 days ago - Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing Loss - GlobeNewsWire
- 9 days ago - Fennec Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 18 days ago - Fennec Pharmaceuticals Announces Closing of Offering of Common Shares - GlobeNewsWire
- 21 days ago - Fennec Pharmaceuticals Announces Private Offering of Common Shares in Canada - GlobeNewsWire
- 21 days ago - Fennec Pharmaceuticals Announces Pricing of Offering of Common Shares - GlobeNewsWire
- 22 days ago - Fennec Pharmaceuticals Announces Proposed Offering of Common Shares - GlobeNewsWire
- 3 months ago - Fennec Pharmaceuticals Inc. (FENC) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Fennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business Update - GlobeNewsWire